Le Lézard
Classified in: Health
Subjects: PARTNERSHIPS, HEALTH

Admera Health Teams with Allure Specialty Pharmacy to Offer PharmD Fellowship Program


SOUTH PLAINFIELD, N,J., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Today, Admera Health, a molecular diagnostics company, in conjunction with Allure Specialty Pharmacy announced the launch of a Post-Doctoral PharmD Fellowship Program focused on pharmacogenomics. The Admera Health-Allure Specialty Pharmacy Program is a multi-site fellowship program that includes two longitudinal experiences integrated over 24 months and is designed to offer an in-depth experience in pharmacogenomics from the standpoint of medical education as well as clinical integration at an ambulatory care pharmacy.

The industry component of the fellowship will be based at Admera Health's headquarters in South Plainfield, New Jersey. The fellow will be an integral member of the medical affairs team and gain working knowledge of the role through broad hands-on experiences and longitudinal core responsibilities. "The field of pharmacogenomics presents with diverse opportunities for pharmacists. As a medication expert, pharmacists are perfectly poised to play a leading role in implementing pharmacogenomics.  This unique fellowship program opens the door to expand pharmacists' role and become well-rounded in this growing field," stated Sanjeda Chumki, PharmD, Fellowship Program Director at Admera Health.

The clinical component of the fellowship will be based at Allure Specialty Pharmacy headquarters in Bronx, New York and its affiliated ambulatory care. The fellow will be an essential part of the pharmacy team, serving as an educator for patients and health care providers on the integration of pharmacogenomics to better determine targeted medication regimens. "The Fellowship Program in Pharmacogenomics bridges the gap between science and clinical practice.  The multi-site program allows for a candidate to build a solid foundation in medical education regarding pharmacogenomics, as well as, implementing pharmacogenomics into clinical medication decision-making in patient care," stated Ronnie Moore, PharmD, Fellowship Program Director at Allure Specialty Pharmacy.

About Admera Health

Admera Health is a CLIA-certified and CAP-accredited advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing, digital health, and providing research use only services. Research and development efforts are dedicated to developing cutting-edge diagnostics that span the continuum of care. Utilizing next generation technology platforms and advanced bioinformatics, Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions. It is our mission to deliver transformative, valuable solutions to patients, physicians, and clinical researchers. We are committed to improving the health and well-being of our global community through the direct delivery of personalized, medically actionable results.

About Allure Specialty Pharmacy

Allure Specialty Pharmacy provides pharmacogenomic targeted disease state management in the clinical areas of psychiatry, pain management, and cardiology.  As well as, providing medication management education for patients suffering from chronic medical conditions: asthma, diabetes, hypertension, hyperlipidemia, etc. Allure Specialty Pharmacy is committed to improving the quality of patients' lives through innovative customized pharmaceutical treatments and superior customer service.

Admera Health Contact:

Sanjeda Chumki, PharmD
Fellowship Program Director
908-222-0533 ext. 3836
[email protected]

Allure Specialty Pharmacy Contact:

Ronnie Moore, PharmD
Fellowship Program Director
866-293-1559
[email protected]


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: